Key result
LACE score-based risk management tool linked to ~45% fewer readmissions in long-term home care patients.
Why the study?
Effectively predicting and reducing readmission in long-term home care is challenging.
Does a LACE score-based risk management tool reduce readmission rates in long-term home care patients?
Cohort (n=180)
No
Does a LACE score-based risk management tool reduce readmission rates in long-term home care patients?
Absolute Event Rate: 14% vs 25.3%
A LACE score-based risk management tool significantly reduced 30-day readmissions by 44.7% in long-term home care patients.
May support LACE tools in home care cohorts; leaves open need for RCTs before practice change.
BACKGROUND: Effectively predicting and reducing readmission in long-term home care (LTHC) is challenging. We proposed, validated, and evaluated a risk management tool that stratifies LTHC patients by LACE predictive score for readmission risk, which can further help home care providers intervene with individualized preventive plans. METHOD: A before-and-after study was conducted by a LTHC unit in Taiwan. Patients with acute hospitalization within 30 days after discharge in the unit were enrolled as two cohorts (Pre-Implement cohort in 2017 and Post-Implement cohort in 2019). LACE score performance was evaluated by calibration and discrimination (AUC, area under receiver operator characteristic (ROC) curve). The clinical utility was evaluated by negative predictive value (NPV). RESULTS: There were 48 patients with 87 acute hospitalizations in Pre-Implement cohort, and 132 patients with 179 hospitalizations in Post-Implement cohort. These LTHC patients were of older age, mostly intubated, and had more comorbidities. There was a significant reduction in readmission rate by 44.7% (readmission rate 25.3% vs. 14.0% in both cohorts). Although LACE score predictive model still has room for improvement (AUC = 0.598), it showed the potential as a useful screening tool (NPV, 87.9%; 95% C.I., 74.2-94.8). The reduction effect is more pronounced in infection-related readmission. CONCLUSION: As real-world evidence, LACE score-based risk management tool significantly reduced readmission by 44.7% in this LTHC unit. Larger scale studies involving multiple homecare units are needed to assess the generalizability of this study.
No takes yet. Share an insight, caveat, or question.
Su et al. (2021) conducted a cohort in Long-term home care patients (n=180). LACE score-based risk management tool vs. Pre-implementation standard care was evaluated on Readmission rate. A LACE score-based risk management tool significantly reduced the readmission rate from 25.3% to 14.0% in long-term home care patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: